Case series characterizes immune checkpoint inhibitor-induced myasthenia gravis-like symptoms, indicating potential overlap with myositis and myocarditis.
To characterize immune checkpoint inhibitor (ICI) induced myasthenia gravis (MG)-like clinical presentation and overlap manifestations with myositis and/or myocarditis.
No takes yet. Share an insight, caveat, or question.
Pucci et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: